Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Cord Blood T Regulatory Cells Can Dampen Cytokine Release Syndrome and Improve on Target Efficacy of CD19 CAR T Cells

Ke Zeng, MD, Li Li, MD, Meixian Huang, MD,PhD, Mi-Ae Lyu, PhD, Mitsutaka Nishimoto, MD, PhD, Hongbing Ma, MD, PhD, Tara Sadeghi, Loretta J. Nastoupil, MD, Krina K. Patel, MD, Sairah Ahmed, MD, Simrit Parmar, MD, MSCI

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-138812

Published: 2020

Journal Articles

Adoptive Therapy with Cord Blood T Regulatory Cells Enhances Anti-Myeloma Efficacy of T Cell Based Immunotherapies

Mitsutaka Nishimoto, MD PhD, Li Li, MD, Meixian Huang, MD,PhD, Mi-Ae Lyu, PhD, Ke Zeng, MD, Hongbing Ma, MD PhD, Tara Sadeghi, Sairah Ahmed, MD, Nina Shah, MD, Krina K. Patel, MD, Simrit Parmar, MD, MSCI

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-143142

Published: 2020

Journal Articles

Adoptive Cord Blood T Regulatory Cell Therapy Leads to Resolution of Inflammation and Decreased Proteinuria in Lupus Nephritis

Mi-Ae Lyu, PhD, Joseph D. Khoury, MD, Meixian Huang, MD,PhD, Mitsutaka Nishimoto, MD PhD, Ke Zeng, MD, Li Li, MD, Hongbing Ma, MD PhD, Tara Sadeghi, Simrit Parmar, MD, MSCI

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-140420

Published: 2020

Journal Articles

Novel CD4 + CD8 + Umbilical Cord Blood Regulatory T Cells

Meixian Huang, Amit Verma, MBBS, Ke Zeng, MD PhD, Mi-Ae Lyu, PhD, Mitsutaka Nishimoto, MD PhD, Hongbing Ma, MD PhD, Zheng Yin, PhD, Swaminathan P. Iyer, MD, Simrit Parmar, MBBS

Blood (2019) 134 (Supplement_1): 4446.

https://doi.org/10.1182/blood-2019-131948

Published: 2019

Journal Articles

Phase I Clinical Trial of CK0801 (cord blood regulatory T cells) in Patients with Bone Marrow Failure Syndrome (BMF) Including Aplastic Anemia, Myelodysplasia and Myelofibrosis

Tapan M. Kadia, MD, Hongbing Ma, MD PhD, Ke Zeng, MD PhD, Mitsutaka Nishimoto, MD PhD, Mi-Ae Lyu, PhD, Meixian Huang, Musa Yilmaz, MD, Courtney D. DiNardo, MDMSc, Ghayas C. Issa, MD, Simrit Parmar, MBBS, Swami P. Iyer, MD, Parameswaran Hari, MBBS, MD, Naval G. Daver, MD, Elias Jabbour, MD, Gautam M. Borthakur, MD, Srdan Verstovsek, MD PhD

Blood (2019) 134 (Supplement_1): 1221.

https://doi.org/10.1182/blood-2019-127702

Published: 2019

Journal Articles

Allogeneic Cord Blood Regulatory T Cells Can Prevent Graft Vs. Host Disease and Preserve Graft Vs Leukemia Effect: Update on Phase I/II Clinical Trial

Ke Zeng, MD PhD, Hongbing Ma, MD PhD, Uday Popat, MD, Yago Nieto, MD PhD, Stefan O. Ciurea, MD, Amanda L. Olson, MD, Mi-Ae Lyu, PhD, Meixian Huang, Mitsutaka Nishimoto, MD PhD, Muzaffar H. Qazilbash, MD, Jennifer D Ramos, RN, Elizabeth J. Shpall, MD, Richard E. Champlin, MD, Simrit Parmar, MBBS, Borje S Andersson, MD PhD

Blood (2019) 134 (Supplement_1): 4547.

https://doi.org/10.1182/blood-2019-127726

Published: 2019

Journal Articles

Adoptive Therapy with Cord Blood Regulatory T Cells Can Treat Graft Vs Host Disease

Hongbing Ma, MD PhD, Ke Zeng, MD PhD, Mitsutaka Nishimoto, MD PhD, Mi-Ae Lyu, PhD, Meixian Huang, Swaminathan P. Iyer, MD, Simrit Parmar, MBBS

Blood (2019) 134 (Supplement_1): 1940.

https://doi.org/10.1182/blood-2019-129395

Published: 2019

NARROW

Cord Blood T Regulatory Cells Can Dampen Cytokine Release Syndrome and Improve on Target Efficacy of CD19 CAR T Cells

Adoptive Therapy with Cord Blood T Regulatory Cells Enhances Anti-Myeloma Efficacy of T Cell Based Immunotherapies

Adoptive Cord Blood T Regulatory Cell Therapy Leads to Resolution of Inflammation and Decreased Proteinuria in Lupus Nephritis

Novel CD4 + CD8 + Umbilical Cord Blood Regulatory T Cells

Phase I Clinical Trial of CK0801 (cord blood regulatory T cells) in Patients with Bone Marrow Failure Syndrome (BMF) Including Aplastic Anemia, Myelodysplasia and Myelofibrosis

Allogeneic Cord Blood Regulatory T Cells Can Prevent Graft Vs. Host Disease and Preserve Graft Vs Leukemia Effect: Update on Phase I/II Clinical Trial

Adoptive Therapy with Cord Blood Regulatory T Cells Can Treat Graft Vs Host Disease

Email alerts

ASH Publications

American Society of Hematology

Cord Blood T Regulatory Cells Can Dampen Cytokine Release Syndrome and Improve on Target Efficacy of CD19 CAR T Cells

Adoptive Therapy with Cord Blood T Regulatory Cells Enhances Anti-Myeloma Efficacy of T Cell Based Immunotherapies

Adoptive Cord Blood T Regulatory Cell Therapy Leads to Resolution of Inflammation and Decreased Proteinuria in Lupus Nephritis

Novel CD4 + CD8 + Umbilical Cord Blood Regulatory T Cells

Phase I Clinical Trial of CK0801 (cord blood regulatory T cells) in Patients with Bone Marrow Failure Syndrome (BMF) Including Aplastic Anemia, Myelodysplasia and Myelofibrosis

Allogeneic Cord Blood Regulatory T Cells Can Prevent Graft Vs. Host Disease and Preserve Graft Vs Leukemia Effect: Update on Phase I/II Clinical Trial

Adoptive Therapy with Cord Blood Regulatory T Cells Can Treat Graft Vs Host Disease

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only